[The role of clinico-pharmacogenetic associations in the prognosis of the outcomes in pneumonias].

In search of reliable genetic markers of protracted and complicated pneumonia, the authors studied blood groups, haptoglobin phenotype, sulfadimisine acetylation. These markers proved essential for predicting pneumonia course and prognosis.